DealCREATE Medicines, a Cambridge, MA-based clinical-stage CAR-T developer, raised $122 million in a Series B fundraising round led by Newpath Partners, ARCH Venture Partners, and Hatteras Venture Partners.
More on STAT+ →
SERIES B
05/17/2026
Violet Therapeutics, a Norwalk, CT-based preclinical neurodegeneration...
Regulate, a Munich-based science-backed breathwork platform, raised €1.4...
NanoStruct, a Würzburg, Germany-based same-day pathogen detection...
CVRD Health, a Miami-based healthcare services platform, raised $5 million...
Nourish, a New York-based metabolic health clinic, raised $100 million in...
Vêtir, a New York-based AI platform for luxury fashion, raised $5.5...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
